Tag: biomedical
-
Scientists, Investors Form $100M+ Tech Venture Fund
A group of entrepreneurs and leading scientists in the U.K. unveiled a venture investment fund that plans to back start-up companies developing a wide range of ground-breaking technologies.
-
Nanoscale Sponges Deliver Rheumatoid Arthritis Treatment
An engineering lab developed a technique to load molecules from white blood cells into tiny particles that act like sponges to reduce joint damage in lab mice from rheumatoid arthritis.
-
Smartphone Device IDs Dangerous Mosquitoes
A study shows a smartphone-based system can quickly and inexpensively identify the species of mosquito that carries many infectious diseases, as well as a natural enemy of those mosquitoes.
-
FDA to Test New Trial Designs, Assess A.I. Models
FDA plans to pilot test new types of complex clinical trials and is considering a procedure to evaluate machine learning algorithms used in diagnostics.
-
Genomics-Blockchain Company Launches, Raises $4.3 Million
A new enterprise that promises to collect and protect a person’s genomic data with blockchain technology is starting up with the help of a genomics legend and $4.3 million in seed financing.
-
Non-Invasive Imaging Technology Probes Deeper Into Tissue
An imaging process that combines ultrasound and lasers is shown in tests with lab samples and in animals to provide clearer and more detailed images of tissue deeper in the body.
-
Genentech Gains Modular Engineered Antibodies in $5B Deal
A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers.
-
A.I., Imaging Shown to Predict Immunotherapy Success
Researchers in France developed a system for computing data from CT scans and genomic analysis to predict the success for therapies that invoke the immune system in patients with solid-tumor cancers.
-
M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency
M.D. Anderson Cancer Center and a spin-off enterprise formed earlier this month are receiving nearly $50 million in grants from Texas’s state cancer prevention and research agency.
-
UPDATE: 23andMe Shuts Down Open API Access to Raw Data
The personal genetics company 23andMe is closing down access to its raw genomic data for independent software developers.